Mild cognitive impairment: A clinically useful but currently ill-defined concept?

Neurocase

Volumn 8, Issue 6, 2002, Pages 405-410

  Thompson, Siân A ^b   Hodges, John R ^a,b  

^a MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Mild cognitive impairment

Indexed keywords

ALZHEIMER DISEASE; AMNESIA; CLINICAL FEATURE; COGNITIVE DEFECT; DEMENTIA; DIAGNOSTIC IMAGING; HIGH RISK PATIENT; HUMAN; MEDICAL RESEARCH; NEUROPSYCHOLOGICAL TEST; PATIENT CODING; REVIEW;

ALZHEIMER DISEASE; COGNITION DISORDERS; CONCEPT FORMATION; DEMENTIA; DISEASE PROGRESSION; HUMANS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK;

EID: 0036981165     PISSN: 13554794     EISSN: None     Source Type: Journal    
DOI: 10.1093/neucas/8.6.405     Document Type: Review

References (47)

1. Albert MS, Moss MB, Tanzi R, Jones K. Preclinical prediction of AD using neuropsychological tests. Journal of the International Neuropsychological Society 2001; 7: 631-9.
2. Berg L. Clinical Dementia Rating (CDR). Psychopharmacology Bulletin 1988; 24: 637-9.
3. Berrios GE, Hodges JH. Memory Disorders in Psychiatric Practice. Cambridge: Cambridge University Press, 2000.
4. Bondi MW, Monsch AU, Galasko D, Butters N et al. Preclinical cognitive markers of dementia of the Alzheimer type. Neuropsychology 1994; 8: 374-84.
5. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica 1991; 82: 239-59.
6. Celsis P. Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease? Annals of Medicine 2000; 32: 6-14.
7. Convit A, De Asis J, De Leon MJ, Tarshish CY, De Santi S, Rusinek H. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiology of Aging 2000; 21: 19-26.
8. Di Carlo A, Baldereschi M, Amaducci L, Maggi S, Grigoletto F, Scarlato G et al. Cognitive impairment without dementia in older people: Prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. Journal of the American Geriatrics Society 2000; 48: 775-82.
9. Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 2001; 71: 441-7.
10. Fabrigoule C, Rouch I, Taberly A, Letenneur L, Commenges D, Mazaux JM et al. Cognitive process in preclinical phase of dementia. Brain 1998; 121: 135-41.
11. Folstein MF, Robins LN, Helzer JE. The mini-mental state examination. Archives of General Psychiatry 1983; 40: 812.
12. Fox NC, Warrington EK, Seiffer AL, Angnew SK, Rossor MN. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. Brain 1998; 121: 1631-9.
13. Fuld PA, Masur DM, Blau AD, Crystal H, Aronson MK. Object-memory evaluation for prospective detection of dementia in normal functioning elderly: Predictive and normative data. Journal of Clinical and Experimental Neuropsychology 1990; 12: 520-8.
14. Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer's disease: A clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000; 123: 484-98.
15. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349: 1793-6.
16. Grundman M. Vitamin E and Alzheimer disease: The basis for additional clinical trials. American Journal of Clinical Nutrition 2000; 71: 630S-6S.
17. Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R et al. Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 1999; 10: 494-504.
18. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52: 1397-403.
19. Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995; 45: 957-62.
20. Jelic V, Nordberg A. Early diagnosis of Alzheimer disease with positron emission tomography. Alzheimer Disease and Associated Disorders 2000; 14: S109-13.
21. Kennedy AM, Frackowiak RS, Newman SK, Bloomfield PM, Seward J, Roques P et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neuroscience Letters 1995; 186: 17-20.
22. Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Annals of Neurology 2000; 47: 430-9.
23. Levy R. Aging-associated cognitive decline. Working party of the International Psychogeriatric Association in collaboration with the World Health Organization. International Psychogeriatrics 1994; 6: 63-8.
24. Linn RT, Wolf PA, Bachman DL, Knoefel JE, Cobb JL, Belanger AJ et al. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Archives of Neurology 1995; 52: 485-490.
25. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994; 44: 1427-32.
26. Moriss JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH et al. Mild cognitive impairment represents early-stage Alzheimer disease. Archives of Neurology 2001; 58: 397-405.
27. Nebu A, Ikeda M, Fukuhara R, Komori K, Maki N, Hokoishi K et al. Utility of (99m)Tc-HM-PAO SPECT hippocampal image to diagnose early stages of Alzheimer's disease using semiquantitative analysis. Dementia and Geriatric Cognitive Disorders 2001; 12: 153-7.
28. Perry RJ, Hodges JR. Fate of patients with questionable (very mild) Alzheimer's disease: Longitudinal profiles of individual subjects' decline. Dementia and Geriatric Cognitive Disorders 2000; 11: 342-9.
29. Petersen RC, Waring SC, Smith GE, Tangalos EG, Thibodeau SN. Predictive value of APOE genotyping in incipient Alzheimer's disease. Annals of the New York Academy of Sciences 1997; 802: 58-69.
30. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Kokmen E, Tangelos EG. Aging, memory, and mild cognitive impairment. International Psychogeriatrics 1997; 9: 65-9.
31. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology 1999; 56: 303-8.
32. Petersen RC, Dickson DW, Parisi JE, Johnson KA, Ivnik RJ, Smith GE et al. Neuropathological substrate and mild cognitive impairment (abstract). Neurobiology of Aging 2000; 21 (suppl. 1S): S198.
33. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1133-42.
34. Reiman EM, Uecker A, Caselli RJ, Lewis S, Bandy D, De Leon MJ et al. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Annals of Neurology 1998; 44: 288-91.
35. Ritchie K, Touchon J. Mild cognitive impairment: Conceptual basis and current nosological status. Lancet 2000; 355: 225-8.
36. Ritchie K, Artero S, Touchton J. Classification criteria for mild cognitive impairment: A population-based validation study. Neurology 2001; 56: 37-42.
37. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S et al. CAMDEX: A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry 1986; 149: 698-709.
38. Rubin EH, Storandt M, Miller JP, Kinscherf DA, Grant EA, Morris JC et al. A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Archives of Neurology 1998; 55: 395-401.
39. Sherwin BB. Mild cognitive impairment: Potential pharmacological treatment options. Journal of the American Geriatric Society 2000; 48: 431-41.
40. Small GW, La Rue A, Komo S, Kaplan A, Mandelkern MA. Predictors of cognitive change in middle-aged and older adults with memory loss. American Journal of Psychiatry 1995; 152: 1757-64.
41. Swainson R, Hodges JR, Galton CJ, Semple J, Michael A, Dunn BD et al. Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks. Dementia and Geriatric Cognitive Disorders 2001; 12: 265-80.
42. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology 1991; 30: 572-80.
43. Thompson SA, Graham KS, Patterson K, Sahakian BJ, Hodges JR. Is knowledge of famous people disproportionately impaired in patients with early and questionable Alzheimer's disease? Neuropsychology 2002; 16: 344-58.
44. Tierney MC, Szalai JP, Snow WG, Fisher RH, Nores A, Nadon G et al. Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurology 1996; 46: 661-5.
45. Warrington EK, Agnew SK, Kennedy AM, Rossor MN. Neuropsychological profiles of familial Alzheimer's disease associated with mutations in the presenilin 1 and amyloid precursor protein genes. Journal of Neurology 2001; 248: 45-50.
46. Wechsler D. Wechsler Memory Scale - Revised. San Antonio, CA: Psychological Corporation, 1987.
47. Xu Y, Jack CR Jr, O'Brien PC, Kokmen E, Smith GE, Ivnik RJ et al. Usefulness of MRI measures of entorhinal crotex versus hippocampus in AD. Neurology 2000; 54: 1760-7.